Company

RegCell

Biotechnology Research The Limitations of Earlier Attempts to Create Therapeutic Tregs and Competitive Advantages Over Car-treg Approaches. 8 employees

Employees: 8
Contacts: 3
Emails: 3
Phones: 2

LinkedIn Crunchbase

RegCell Overview

Headquarters: The Limitations of Earlier Attempts to Create Therapeutic Tregs and Competitive Advantages Over Car-treg Approaches.
Industry: Biotechnology Research
Employees: 8
Founded: 2016
Funding: 8.5M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Boston

About RegCell

Based on the discovery by our Founder, Professor Shimon Sakaguchi, we are developing stable, functional-induced Tregs that are antigen-specific (S/F-iTregs). Our S/F-iTregs address the limitations of earlier attempts to create therapeutic Tregs and competitive advantages over CAR-Treg approaches.

RegCell Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

RegCell Org Chart

Sample employees and titles

Name	Title	Location	Contact
Brian Peet, Mba	AI Product Consultant I Data Scientist	Boston, Massachusetts, United States	Email
Steven Kanner	Independent Consultant	Berkeley, California, United States	Email Phone
Michael Mccullar	Biotech Executive - CEO - COO - M	Walnut Creek, California, United States	Email Phone
Daisuke Ishikawa	Biotech Executive - Startup - Inversion	Tokyo, Japan	View